OptiBiotix Health enters MoU with Taiwan's Bened Biomedical

Josh White Sharecast | 13 Sep, 2017 16:32 | | |


OptiBiotix Health


17:17 22/09/17
  • 13,020.17
  • 1.37%175.93
  • Max: 13,108.57
  • Min: 12,817.57
  • Volume: 0
  • MM 200 : n/a
17:30 22/09/17
  • 994.67
  • 0.30%2.94
  • Max: 995.03
  • Min: 989.98
  • Volume: 0
  • MM 200 : n/a
17:25 22/09/17

Life sciences business OptiBiotix Health said it has signed a memorandum of understanding with Bened Biomedical of Taiwan on Wednesday.

The AIM-traded firm said the MoU would set the framework for a “strategic partnership” to explore licensing and sales opportunities and the potential of combining relevant assets over the next 12 months.

It said Bened Biomedical was founded in 2015 as a spin-off from National Yang-Ming University by Professor Tsai, Ying-Chieh.

Bened is a leading probiotic research and marketing company, developing microbiome-based products for neuropsychological, allergic, immunological, metabolic and aging-related disorders.

In the past two years, its flagship psychobiotic PS128 products - which reportedly help improve mental and emotional health - had been sold through both online and offline channels in more than 10 countries, generating revenues in the excess of $2m.

OptiBiotix said the MoU provided a 12-month period to explore opportunities relating to its own cholesterol and blood pressure reducing LPLDL strain and Bened's PS128, a psychobiotic that had shown encouraging results in reducing anxiety and depression in animal studies.

“We are pleased to announce this strategic partnership with Bened Biomedical and see a strong rationale for both companies to work together based on a complementary understanding of the science in different application areas of the microbiome,” said OptiBiotix chief executive officer Stephen O'Hara.

“We are excited by recent advances in psychobiotics which have the potential to address a range of mental and emotional health issues such as anxiety, depression, autism and Parkinson's.

“We strongly believe Bened's scientific and commercial capabilities in psychobiotics creates potential for OptiBiotix to bring new products to new markets and extend both our product offering and global reach in the microbiome field to bring better science and better health to all.”

Frankie Cheng, chief executive officer of Bened Biomedical, said that OptiBiotix operated in a “very exciting and progressive” area that had the potential to bring “real” health benefits.

“It has exciting products with strong science and clinical studies which we believe can be commercialised successfully through our distribution capability,” Cheng added.

“We see mutual benefit in OptiBiotix's commercial advances in Europe and US as a way to bring our PS128 product to a wider audience.”

More news

24 Sep Sunday share tips: Stobart Group, 1pm

Stobart Group shares were a 'sell' in the Sunday Times' Inside the City column, sparked by a share sale by former boss Andrew Tinkler to cut his stake to 5.3%.

24 Sep Tullow Oil to restart production from TEN following TLOS ruling

Tullow Oil will begin drilling at its TEN fields offshore Ghana following a favourable ruling by the Special Chamber of the International Tribunal of the Law of the Sea at the weekend.

24 Sep US close: Stocks end on mixed note, North Korea threats weigh

Wall Street ended the session on a mixed note, with a threat from North Korea's top diplomatic official weighing on sentiment.

24 Sep Sunday newspaper round-up: UK property, Treasury, Brexit, banks, Ladbrokes

Foreign buyers will face tougher restrictions on purchasing British property under plans being worked up by the Treasury in an attempt to help first time buyers. Policies could be announced within weeks as getting younger Britons on the housing ladder becomes a major part of the Tories autumn political drive. - Sunday Telegraph

22 Sep Europe close: Stocks finish higher on strong PMI readings

Stocks on the Continent finished mostly higher on the back of strong survey readings on the euro area's manufacturing and services sector and ahead of the German general elections at the weekend, although fresh barbs from Pyongyang were a drag on sentiment.

22 Sep Thousands of steel workers protest ThyssenKrupp merger in Germany

Thousands of steel workers gathered in Western Germany on Friday to protest the proposed merger of ThyssenKrupp and Tata Steel's European operations which was expected to result in approximately 4,000 job losses.

22 Sep London Close: FTSE firmer as pound losses ground after May speech

London stocks had reversed earlier losses to trade a little higher by Friday's close, helped along by a weaker pound as investors weighed up a key speech by Prime Minister Theresa May.

22 Sep JP Morgan Chase to establish global headquarters in Warsaw

Polish Deputy Prime Minister Mateusz Morawiecki announced on Friday that US bank JP Morgan Chase had picked Warsaw to play host to its new global operations centre, bringing thousands of jobs to the region from the beginning of 2018.

22 Sep FTSE 250 movers: Pets at Home dashes higher, oilers also lifted

The FTSE 250 index was on the front foot on Friday, led by retailer Pets at Home and a group of oil-related companies.

22 Sep Theresa May calls for post-Brexit transition period, new security treaty

In a speech in Florence on Friday, Prime Minister Theresa May confirmed that she wanted a two-year "implementation period" post-Brexit and a new treaty with the European Union on security and justice.